ArticleFrontiers in cardiovascular medicine2022

A Comparative Study of the Clinical Benefits of Rivaroxaban and Warfarin in Patients With Non-valvular Atrial Fibrillation With High Bleeding Risk.

Peng-Hui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.